The market for the popular weight loss drug Wegovy (semaglutide) is expanding after Novo Nordisk, the Denmark-based pharmaceutical giant that manufactures it, issued new claims that the controversial pharmaceutical injection supposedly also helps to prevent heart attack, stroke and early death. Conveniently for the company, Wegovy allegedly works against a variety of cardiovascular problems that […]

www.newstarget.com